October 29th 2024
Are SDOHs associated with Medicare, Medicaid, and private insurer spending?
October 24th 2024
How emerging biotech companies can create fruitful partnerships between home office commercial teams and the field force to enable this intelligence gathering, while driving commercial success.
October 22nd 2024
The offering will become available in 49 states by next year.
October 18th 2024
A panel dives into the current and future outlook of healthcare policies.
October 17th 2024
Session dives into how healthcare policy implementation impacts stakeholders long-term.
Pfizer purchases Arena Pharmaceuticals for $6.7 billion
Deal expands pharma giant’s influence in inflammation and immunology markets
Thermo Fisher Scientific completes acquisition of PPD
The $17.4-billion deal, CDMO says, will help expand its offerings in the clinical development space
Bora Pharmaceuticals expands presence in CDMO sector
Via investment partnership with Taishin Holdings, will begin offering manufacturing services in C> space
Recordati to purchase EUSA Pharma
Upon deal completion, group will acquire company’s oncology product portfolio for $846 million
CordenPharma to invest $10.9 million in oral solid drug manufacturing
CDMO’s financial commitment will feature construction of a new GMP clinical trial development facility
Fujifilm to invest $533 million in UK facility
Financial commitment is predicted to more than double the biopharma site’s manufacturing capabilities
Adare Pharma Solutions purchases Frontida BioPharm
Transaction expands CDMO’s services, including more solutions surrounding commercial manufacturing
Lonza and Bioqube sign biologics agreement
Five-year deal covers manufacturing of molecules, ranging from monoclonal antibodies to antibody-drug conjugates
GreenLight Biosciences, Samsung Biologics partner up to develop Covid vaccine candidate
Subject to regulatory approval, CDMO will produce mRNA vaccine on a commercial scale
AstraZeneca opens new $1.3 billion R&D plant
The Discovery Centre will be powered by AI technology, robotics, among other features
Novo Nordisk inks $3.3 billion deal for Dicerna Pharma
Transaction is anticipated to further Novo’s research in the field of RNAi therapeutics
Merck purchases Acceleron Pharma for $11.5 billion
Acquisition of biopharma company features sotatercept, which is in Phase III trials for the treatment of pulmonary arterial hypertension
Sterling Pharma Solutions unveils $13.4 million investment plan for Dudley, UK site
Financial commitment expected to increase plant's process development and manufacturing capacity
The Key Force in CGT Commercialization
Industrialized collaboration is critical to taking next-generation cell and gene therapies to the next level—if companies can build on pandemic-partnering momentum
J&J to branch out its consumer health business
Separation process expected to be completed in 18-24 months
Fujifilm Irvine Scientific further develops its Armstrong R&D Cell Culture Center of Excellence
Expansion expected to more than double the plant’s footprint
Lykan Bioscience to grow its cell therapy manufacturing capabilities
CDMO’s expansion of Hopkinton, MA facility will include seven new ISO 7 cGMP suites
Sever Pharma Solutions purchases Foster Delivery Science
Deal expected to boost firm’s offerings via FDS's delivery system services
The Vistria Group acquires BioCare
Partnership further increases investment firm’s repertoire in healthcare space
PCI Pharma Services to construct Clinical Center of Excellence
Boston area facility will focus heavily on cold chain services
Thread acquires Modus Outcomes in DCT deal
Parties expect improved design and selection of eCOAs in decentralized clinical trials
Partnership tackles barriers to drug adherence
ScriptDrop, Adheris Health collaborate to assist patients with their medication regimens
Cardinal Health granted FDA funding for RWE study
Award will support research based on use of real-world evidence in clinical oncology setting
Aktana secures new machine learning automation technology
Acquisition reportedly increases AI accessibility across life sciences organizations
Catalent commits $230 million to Harmans gene therapy campus
Development project features additional manufacturing suites, expansion of storage capabilities
Biolife Solutions opens ‘Center of Excellence' in Amsterdam
Facility features cell storage for CAR-T cell treatments
Construction of new BioNTech manufacturing plant in Africa to begin mid-2022
mRNA jab maker plans to initially produce 50 million Covid vaccine doses per year
ten23 health acquires swissfillon
Deal provides ten23 with drug product development, biologic manufacturing experience
Avid Bioservices steps into viral vector development space
Biologics manufacturer to construct new C> facility to support expansion
Evergreen Theragnostics finishes New Jersey manufacturing plant
Facility meets cGMP standards for radiopharmaceutical production